Completed OBSERVATIONAL NCT01013922

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for COPD in a Primary Care Setting

Sponsor: AstraZeneca

Conditions Chronic Obstructive Pulmonary Disease

Updated 7 times since 2017 Last updated: Nov 18, 2010 Started: Oct 31, 2009 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chronic Obstructive Pulmonary Disease and is currently completed. AstraZeneca leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alingsås, Sweden , Arvidsjaur, Sweden , Askim, Sweden , Bromma, Sweden , Eslöv, Sweden , Falun, Sweden , Gagnef, Sweden , Gothenburg, Sweden , Hagfors, Sweden , Helsingborg, Sweden and 13 more locations